MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from warrant
inducements, net of issuance...
$51,042K
Proceeds from issuance of
common stock, common...
$23,051K
Proceeds from the
exercise of common stock...
$12,618K
Proceeds from employee
stock plan purchases
$112K
Net cash provided by
financing activities
$86,296K
Canceled cashflow
$527K
Net increase in
cash, cash...
$57,907K
Canceled cashflow
$28,389K
Tax withholding on
vesting of restricted...
$527K
Non-cash stock-based
compensation
$1,956K
Non-cash lease expense
$597K
Net cash used in
operating activities
-$28,389K
Canceled cashflow
$2,553K
Net loss
-$26,863K
Accrued expenses and
other current...
-$1,941K
Prepaid expenses and
other assets
$968K
Operating lease
liabilities
-$635K
Accounts payable
-$535K
Back
Back
Cash Flow
source: myfinsight.com
SELLAS Life Sciences Group, Inc. (SLS)
SELLAS Life Sciences Group, Inc. (SLS)